Cited by 792Hormonal and reproductive studiesBone health and osteoporosis researchGrowth Hormone and Insulin-like Growth Factors

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

Katznelson, L, Finkelstein, J S, Schoenfeld, D A, Rosenthal, D I, Anderson, E J, Klibanski, A·1996·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem.81.12.8954042

Open this paper in CoChat — free account

Abstract

Acquired hypogonadism is being increasingly recognized in adult men. However, the effects of long term testosterone replacement on bone density and body composition are largely unknown. We investigated 36 adult men with acquired hypogonadism (age, 22-69 yr; median, 58 yr), including 29 men with central hypogonadism and 7 men with primary hypogonadism, and 44 age-matched eugonadal controls. Baseline evaluation included body composition analysis by bioimpedance, determination of site-specific adipose area by dual energy quantitative computed tomography scan (QCT) of the lumbar spine, and measurements of spinal bone mineral density (BMD) using dual energy x-ray absortiometry, spinal trabecular BMD with QCT, and radial BMD with single photon absorptiometry. Percent body fat was significantly greater in the hypogonadal men compared to eugonadal men (mean +/- SEM, 26.4 +/- 1.1% vs. 19.2 +/- 0.8%; P < 0.01). The mean trabecular BMD determined by QCT for the hypogonadal men was 115 +/- 6 mg K2HPO4/cc. Spinal BMD was significantly lower than that in eugonadal controls (1.006 +/- 0.024 vs. 1.109 +/- 0.028 g/cm2; P = 0.02, respectively). Radial BMD was similar in both groups. Testosterone enanthate therapy was initiated in 29 hypogonadal men at a dose of 100 mg/week, and the subjects were evaluated at 6-month intervals for 18 months. During testosterone therapy, the percent body fat decreased 14 +/- 4% (P < 0.001). There was a 13 +/- 4% decrease in subcutaneous fat (P < 0.01) and a 7 +/- 2% increase in lean muscle mass (P = 0.01) during testosterone therapy. Spinal BMD and trabecular BMD increased by 5 +/- 1% (P < 0.001) and 14 +/- 3% (P < 0.001), respectively. Radial BMD did not change. Serum bone-specific alkaline phosphatase and urinary deoxypyridinoline excretion, markers of bone formation and resorption, respectively, decreased significantly over the 18 months (P = 0.003 and P = 0.04, respectively). We conclude that testosterone therapy given to adult men with acquired hypogonadism decreases sc fat and increases lean muscle mass. In addition, testosterone therapy reduces bone remodeling and increases trabecular bone density. The beneficial effects of androgen administration on body composition and bone density may provide additional indications for testosterone therapy in hypogonadal men.

Integrity signals

Registry

Crossref · 10.1210/jcem.81.12.8954042

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Hip fractures in the elderly: A world-wide projection
Cooper, C. C., Campion, G., & Melton, L. J. (1992) · Osteoporosis International · doi:10.1007/bf01623184 · Cited by 3,225
Measurement of Bone Mineral in vivo: An Improved Method
CAMERON, J. R., & Sorenson, J. A. (1963) · Science · doi:10.1126/science.142.3589.230 · Cited by 827
Effects of testosterone supplementation in the aging male.
Tenover, J. S. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400877 · Cited by 702
Risk factors for spinal osteoporosis in men
Seeman, E., Melton, L. J., O’Fallon, W. M., & Riggs, B. L. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90878-1 · Cited by 658
Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
Urban, R. J., Bodenburg, Y. H., Gilkison, C., Foxworth, J., Coggan, A. R., Wolfe, R. R., & Ferrando, A. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.269.5.e820 · Cited by 608
Osteoporosis: Etiology, diagnosis, and management
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80791-1 · Cited by 605
Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels
Seidell, J. C., Björntorp, P., Sjöström, L., Kvist, H., & Sannerstedt, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90297-p · Cited by 567
Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study
Morley, J. E., Perry, H. M., Kaiser, F. E., Kraenzle, D., Jensen, J., Houston, K., Mattammal, M. B., & Perry, H. M. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb02049.x · Cited by 462
Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor.
Bellido, T., Jilka, R. L., Boyce, B. F., Girasole, G., Broxmeyer, H. E., Dalrymple, S. A., Murray, R., & Manolagas, S. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117995 · Cited by 429
Castrated Men Exhibit Bone Loss: Effect of Calcitonin Treatment on Biochemical Indices of Bone Remodeling*
Stepan, J. J., Lachman, M., ZVĚŘINA, J., Pacovský, V., & Baylink, D. J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-523 · Cited by 423

Show all 38 references

Sorted by citations

Items 701–792 of 792

Testosterone Therapy for Osteoporosis in Men
Lakshman, K. M., Bhasin, S., & Araujo, A. B. (2010) · Osteoporosis in Men · doi:10.1016/b978-0-12-374602-3.00056-0 · Cited by 1
Androgens and Body Composition
Katznelson, L. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_13
Self-citation
The interrelationship of sex steroid levels, body composition and bone characteristics in men
Lapauw, B. (2009) · Ghent University Academic Bibliography (Ghent University)
Hypogonadism in Men With HIV-AIDS
Bhasin, S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-727-7_11
The Osteogenic Effects of 12 Weeks of Oral Supplementation of Androstenedione in Middle-Aged Men.
Wills, T. (2003) · Digital Commons - East Tennessee State University (East Tennessee State University)
Exercício físico e melatonina promovem conjuntamente redução da adiposidade em ratos, embora estes se tornem hipogonádicos.
de Proença, A. R. G. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2013.tde-18062014-155708
Doping in Children and Adolescents
Rawson, E. S., & Persky, A. M. (2007) · Wiley eBooks · doi:10.1002/9780470696255.ch21
Hormonwirkungen und Hormontherapie
Schubert, M., Jockenhövel, F., Brüning, J. C., Allolio, B., Callies, F., Lerchl, A., Gerhards, S., Kühnert, B., & Nieschlag, E. (2004) · Springer eBooks · doi:10.1007/978-3-642-18705-6_2
Genetic and Functional Analysis of Androgen Receptor Gene Mutations
Brüggenwirth, H. T. (1998) · EUR Research Repository (Erasmus University Rotterdam)
Auswirkungen von transdermalem Testosterongel auf Marker des Knochenumsatzes und die Knochendichte bei hypogonadalen Männern
Wang, C., Berman, N., Cunningham, G. R., Dobs, A. S., Iranmanesh, A., Matsumoto, A. M., Snyder, P., Swerdloff, R. S., & Weber, T. J. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Exogenous androgens: effect on spermatogenesis
Khera, M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997761.030
Androgens, Skeletal Homeostasis, and Osteoporosis
Vanderschueren, D., Vandenput, L., Verstuyf, A., Swinnen, J. V., Bouillon, R., & Boonen, S. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1161-8_16
Die Osteoporose des Mannes
Dobnig, H. (2010) · Osteologie/Osteology · doi:10.1055/s-0037-1619934
“Teriparatid wird insgesamt gut vertragen, Nebenwirkungen sind meist milder Natur und beinhalten (bei weniger als zehn Prozent der Patienten) leichtes Schwindelgefühl und Wadenkrämpfe.”
BackgroundInfluential
Pharmacological Management of the Obese Patient
Schumacher, D. (2013) · American Journal of Lifestyle Medicine · doi:10.1177/1559827613504733
Osteopatías endocrinas (exceptuando el hiperparatiroidismo)
Cortet, B., Cortet‐Rudelli, C., & Trémollières, F. (2001) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(01)72225-3
Ostéoporose de l’hypogonadisme masculin
Devogelaer, J., & Maiter, D. M. (2001) · Revue du Rhumatisme · doi:10.1016/s1169-8330(01)00165-x
VIII. Conclusion--Research Design Issues in Examining the Effects of Testosterone Supplementation in Older Men
Bhasin, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5060-8
Osteoporosis in Men: The Quieter Half of a Silent Disease
Olszynski, W. P., & Davison, K. S. (2005) · Aging Health · doi:10.2217/1745509x.1.2.263
Testosterone-Induced Changes in Markers of Bone Turnover in Adolescent Boys with Testicular Dysfunction
Ogawa, E., Katsushima, Y., Fujiwara, I., & Iinuma, K. (2003) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.12.81
“It has also been shown in adults that T therapy causes a reduction in resorption markers with an increase in BMD, whereas changes in bone formation markers are varied (3, 4, 12).”
Background
Androgen Deficiency in Men Without Overt Pituitary-Gonadal Disease: The Role of Testosterone Therapy
Bhasin, S. (2000) · Endocrine updates · doi:10.1007/978-1-4757-6507-6_6
The Brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) - Four-stage translation and validation Versão brasileira do questionário "Quality of Life - Assessment of Growth Hormone Deficiency in Adults" (QoL-AGHDA) - Tradução e validação em quatro estágios
Ribeiro‐Oliveira, A., Mol, S. S., Twiss, J., et al. (2010)
Effect of creatine monohydrate supplementation for 3 weeks on testosterone conversion to dihydrotestosterone in young rugby players
van der Merwe, J. (2006) · SUNScholar (Stellenbosch University)
Androgens and Skeletal Homeostasis
Vanderschueren, D., Vandenput, L., Swinnen, J. V., Boonen, S., & Bouillon, R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_18
Male hormonal contraception: a safe option?
Walton, M. J., & Anderson, R. A. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.25
Diagnose der Osteoporose beim Mann
Kudlacek, S., & Willvonseder, R. (2003) · Blickpunkt der Mann
For information on reprint requests of more than 101 and commercial reprints contact
Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Edwards, H. A. (2008)
Obesity, Leptins, Hypogonadism and Waist–Hip Ratio in men: An Interplay
Elizabeth, J., Rakshita, C., & Ramkumar, S. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1788-1_150
Bisphosphonates for preventing and treating osteoporosis in men
Sim, I., Ebeling, P. R., & Buchbinder, R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011074
Retracted
Effect of Testosterone on Hind Limb Regeneration in Tadpoles of the Egyptian Toad, Bufo Regularis Reuss
Hamdi, H., El-Ghareeb, A.-W., Shamakh, A., & Saeed, S. (2011)
androgen administration to amend age-related decrements Higher muscle protein synthesis in women than men across the lifespan, and failure of (PDF)
Shen, R., Storer, T. W., Dzekov, C., Dzekov, J., Bross, R., Phillips, J. D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., et al. (2009)
Androgens and the Skeleton – Humans
Leder, B. Z. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00026-2
Diagnosis and Treatment of Male Osteoporosis
ORWOLL, E. S. (1999) · Endocrine updates · doi:10.1007/978-1-4615-5115-7_12
Rasprostranennost' osteopenicheskogo sindroma i osobennosti kostnogo metabolizma u zdorovykh detey primorskogo kraya
Васильева, Т. Г., Maksimova, O. G., & Kochetkova, E. A. (2006) · Osteoporosis and Bone Diseases · doi:10.14341/osteo2006311-13
Pitfalls of Androgen Deprivation Therapy
Morgans, A. K., & Smith, M. R. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-259-9_23
Relationships of Leptin and Sex Hormones with the Body Mass Index and Waist/Hip Ratio in Aging Taiwanese Males
Chen, H., Tsai, T., & Hwang, T. I. S. (2006) · Urological Science
AUTHOR PROOF COPY Not for publication The many faces of testosterone
Bain, J. (2007)
Endocrine Society Clinical Practice Guideline Testosterone Therapy in Men with Androgen Deficiency Syndromes: An
Montori, V. M., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., & Ronald, S. H. (2010)
EXERCÍCIO FÍSICO E MELATONINA PROMOVEM CONJUNTAMENTE REDUÇÃO DA ADIPOSIDADEEM RATOS, EMBORA ESTES SE TORNEM HIPOGONÁDICOS
de Souza, F. M. B. (2013)
Effects of soy isoflavones on the hypothalamic-pituitary system in rats: a morphofunctional study
Trifunović, S. L. (2012) · doi:10.2298/bg20120710trifunovic
Androgen Actions on Bone: Clinical Aspects
Goemaere, S., T'Sjoen, G. G., & Kaufman, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-459-9_17
Diferentes respuestas somáticas y densitométricas sobre el hueso cortical y trabecular a la androgenoterapia en varones hipogonádicos. Different somatic and densitometric responses of cortical and trabecular bone to androgen therapy in hypogonadal men.
Aszpis, S., Karlsbrum, S., Salerni, H., Otero, P., Schurman, L., & Levalle, O. A. (2007)
Preservation strategies
Applegarth, L. D., Oates, R. D., & Schlegel, P. N. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997761.020
Androgens in Male Sexual Physiology
McMahon, C. G. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7234-3266-1.50010-3
Markers of Bone Remodeling and the Aging Skeleton
Cremers, S., Meier, C., & Seibel, M. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00014-6
Endogenous serum testosterone in man : ageing, the metabolic syndrome, functional decline and the role of supplementation.
Haren, M. T. (2005) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Progressive Bone Loss due to Androgen Deprivation Therapy for Prostate Cancer: A Meta-analysis
Shimada, S., Yokoyama, N., Origasa, H., Tsuneki, H., & Kimura, I. (2005) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.31.203
Obesity and Aging in Late-Onset Hypogonadism
Rastrelli, G., & Wu, F. C. W. (2017) · Springer eBooks · doi:10.1007/978-3-319-53298-1_17
Causas y consecuencias del hipogonadismo en varones con diabetes mellitus tipo 2
Ruiz, A. H. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128430
Vliyanie somatotipa na mineral'nuyu plotnost' kostey skeleta, massu myshechnoy, soedinitel'noy i zhirovoy tkaney
Свешников, А. А., & Парфенова, И. А. (2006) · Osteoporosis and Bone Diseases · doi:10.14341/osteo200637-10
Effect of the Resistance Exercise-Induced Hormonal Changes on Satellite Cell Myogenic State
Luk, H. Y. (2018) · doi:10.12794/metadc1157528
Antiaging and Performance-Enhancing Drugs
Yaseen, Z. (2018) · Springer eBooks · doi:10.1007/978-3-319-16223-2_6
Gesundheitsvorsorge für den älteren Mann: Präventionskonzepte aus internistischer Sicht
Ae, H., & Despeghel-Schoene, M. (2004) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Male Reproductive Aging
Snyder, P. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00016-0
Ergogenic Aids
Levy, J. L., Cabrera, J., Thomas, S. F., & Brennan, F. H. (2008) · Elsevier eBooks · doi:10.1016/b978-141603197-0.10048-5
Testosterone replacement therapy in puberty
Bouvattier, C. M., & Young, J. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.05.005
Testosterone and the aging male: To treat or not to treat?
Baina, J. (2010)
연령별 남성호르몬 농도와 비만지표들과의 연관성
Lee, Y., 김현주, & Hee, K. M. (2014)
남성호르몬 농도와 비만지표들과의 연관성
Kim, C. H. (2015)
Pharmacological therapies for the prevention of fractures in men
Bråten, L. C. H., Johnston, R. V., Suter, C., Saku, S. A., Järvinen, T. L. N., & Buchbinder, R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014707
Effects of metabolic syndrome on erectile dysfunction
Khan, A. I., Enobakhare, O., Stoddard, M. D., Eidelberg, A., Punjani, N., & Kashanian, J. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819765-3.00014-5
Testosterone replacement in men
Beg, S., Al-Khoury, L., & Cunningham, G. R. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32831550c5
未病管理の方法 6) 男性のためのホルモン補充療法
政壽, 野., 敏彦, 柳., 涼一, 高., & 名和田, 新. (2000) · 日本未病システム学会雑誌 · doi:10.11288/mibyou1998.6.209
Benefits of Testosterone Treatment
Basaria, S. S., & Gagliano‐Jucá, T. (2022) · doi:10.1093/med/9780198870197.003.0489
Faculty Opinions recommendation of Gonadal steroids and body composition, strength, and sexual function in men.
Burger, H. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718106470.793483637
Chronic Pain and Opioids
Cheatle, M. D., & Gallagher, R. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-95369-4_25
Osteoporosis in Men
ORWOLL, E. S., & Klein, R. F. (2003) · doi:10.1007/978-1-4757-4561-0_10
Male Osteoporosis
Arya, V. (2006) · Apollo Medicine · doi:10.1016/s0976-0016(11)60207-x
Anabolic Steroids
(2008) · CRC Press eBooks · doi:10.1201/9780849378812.ch7
O kongressakh i simpoziumakh
- (2006) · Osteoporosis and Bone Diseases · doi:10.14341/osteo2006348-48
Andrologie
(2013) · Andrologie · doi:10.1007/12610.1760-5377
Pharmacokinetics of Modified Slow-Release Oral Testosterone over 10 Days in Normal Men with Experimental Hypogonadism
Lee, A. P., Rubinow, K. B., Clark, R. V., Caricofe, R. B., Bush, M., Zhi, H., Roth, M. Y., Page, S. T., Bremner, W. J., & Amory, J. K. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part1.p15.p1-346
THE CLINICAL SIGNIFICANCE OF THE TOTAL AND FREE TESTOSTERONE IN AGING MEN
Enany, S. I., Kandee, H. T., Abd-El-Lateef, N., & Hussein, M. A. R. (2003) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2003.18247
References
(2009) · Wiley eBooks · doi:10.1002/9780470824023.refs
Androgens
Mukaddam, M. A., & Snyder, P. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00078-2
Benefits of Testosterone Replacement and Methods of Substitution
Ho, K. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109345
70 Yaş ve Üzeri Erkek Cinsiyette Kemik Mineral Dansitesinin İnsülin Benzeri Büyüme Faktörü 1 ve Estradiol Düzeyleri ile İlişkisi
Önder, Ç. E., & Yılmaz, N. (2023) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · doi:10.20492/aeahtd.1328824
Testosterone and the Older Man
Tenover, J. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-375-0_21
Androgen Replacement Therapy of Male Hypogonadism
Meikle, A. W. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-375-0_19 · Cited by 1
10.1016/s1047-9422(03)00083-x
(2000) · Time to knit · doi:10.1016/s1047-9422(03)00083-x
10.1016/s0246-0521(19)30290-6
(2000) · Time to knit · doi:10.1016/s0246-0521(19)30290-6
10.1016/s1155-1941(19)30033-2
(2000) · Time to knit · doi:10.1016/s1155-1941(19)30033-2
Testosterone and Osteoporosis
Vincentis, S. D., David, K., Antonio, L., & Rochira, V. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_22
Erkrankungen der Hoden (einschließlich Gynäkomastie)
Mann, K., & Harstrick, A. (1999) · Springer eBooks · doi:10.1007/978-3-662-10477-4_56
Androgen Administration in Sarcopenia Associated with Chronic Illness
Bhasin, S., Singh, A. B., Beck, K., & Woodhouse, L. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-375-0_22
Treatment Options for Testosterone Replacement Therapy
Khera, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_10
Mechanisms and effects of growth hormone deficiency (due to subarachnoid haemorrhage and traumatic brain injury) on quality of life and regional body composition, and the influence of hormone replacement.
Gardner, C. (2015) · University of Liverpool · doi:10.17638/02006206
Applications of Androgen Therapy for Muscle Wasting Associated with Human Immunodeficiency Virus-Infection and Other Chronic Diseases
Bhasin, S., & Javanbakht, M. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-700-0_19
Sarcopenic Obesity and Hormones: A Narrative Review
Yu, D., & Zhou, B. (2025) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2025.1312003
Bone health and cardiovascular risk in hypopituitary patients on complete hormone replacement, including GH
Holmer, H. (2007) · Lund University Publications (Lund University)
Androgen and Estrogen Effects on Plasma Lipids in Men
Bagatell, C. J., & Bremner, W. J. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-708-6_14
Die Auswirkungen von ß-Ecdyson auf die Histomorphologie des Myokards der orchiektomierten Sprague-Dawley-Ratte als Modell des androgendefizienten älteren Mannes
Eismann, J. (2014) · doi:10.53846/goediss-4383
The associations between genetic variants body composition, and blood pressure in Afro-Caribbean men from Tobago
Beason, T. S. (2010) · D-Scholarship@Pitt (University of Pittsburgh)

Authors: Katznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A.
Affiliations: Massachusetts General Hospital (US)
ORCID: Katznelson, L
Finkelstein, J S
Schoenfeld, D A
Rosenthal, D I
Anderson, E J
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 1996-12
Volume: 81
Issue: 12
Pages: 4358-4365
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem.81.12.8954042
OpenAlex: W1974568933
Semantic Scholar: 829db808d1847d263af6c33d3397743284ea9f83
Cited by: 791
References: 38
Citations by year: 2026: 2 · 2025: 9 · 2024: 12 · 2023: 13 · 2022: 16 · 2021: 15 · 2020: 15 · 2019: 14 · 2018: 17 · 2017: 18 · 2016: 22 · 2015: 24 · 2014: 17 · 2013: 29 · 2012: 35
FWCI: 19.42
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5f32dk008738-02)
National Institute of Diabetes and Digestive and Kidney Diseases (DK-08738)
National Center for Research Resources (RR 01066, M01RR001066)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords: testosterone replacement therapy, testosterone enanthate, bone mineral density, trabecular bone density, lean body mass, body composition, fat mass, central hypogonadism, hypergonadotropic hypogonadism, bone-specific alkaline phosphatase, urinary deoxypyridinoline, bone turnover markers, men's health, osteoporosis prevention
MeSH terms: Adult, Aged, Body Composition, Bone Development, Humans, Hypogonadism, Cholesterol, HDL, Longitudinal Studies, Male, Middle Aged, Parathyroid Hormone, Growth Hormone, Testosterone, Bone Density

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks